A potent, cell-permeable, irreversible, and selective inhibitor of EGF receptor (EGFR) tyrosine kinase activity (IC=0.70 nM. Does not inhibit other protein kinases. Acts by binding to the catalytic domain of the EGFR with a 1:1 stoichiometry and alkylating Cys. Excellent antitumor agent in vivo.
Additional Information
Synonyms
4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline
Product #
P-1653
Chemical Name
4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline
Formula
C17H13BrN4O
MW
369.2
Appearance
Orange-yellow Solid
Purity
95%
Solubility
Soluble in DMSO
Storage Temp
-20°C
Therapeutic Area
Oncological Disorders
Use
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer